Menu
中文Book a checkup
Chang Gung Memorial Hospital Taipei Health Examination Center · Taipei

Standard Painless GI Endoscopy Package

US$763
NT$24,500 · you pay the hospital in NT$

Women: US$841 (NT$27,000). The price above is for men.

Book this checkup

Prefer to book it yourself? Call Chang Gung Memorial Hospital Taipei on (02)2713-6500 ext. 2 / (02)2719-7271 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A specialty-tier program with Colonoscopy, Gastroscopy (upper GI endoscopy), Abdominal ultrasound, Breast ultrasound and 10-year cardiovascular risk score and a 71-test panel, with a doctor's review at the end.

Sedation
Available
Lead time
14 days
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Colonoscopy

Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.

Gastroscopy (upper GI endoscopy)

Stomach and esophagus ulcers, inflammation and cancer.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Every test, in English

71 tests listed, 56 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count2
Liver Function6
Kidney & Electrolytes6
Lipids & Cardiometabolic4
Glucose2
Thyroid & Endocrine2
Tumor Markers9
Infection Serology4
Urine & Stool2
Cardiac2
Pulmonary1
X-ray2
Ultrasound2
Endoscopy2
Women's Health1
Eye3
Consultation1
Show all 71 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Total bilirubinJaundice, liver and bile problems.
Total proteinNutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CalciumBone, parathyroid and kidney conditions.
CreatinineKidney function.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.
PhosphorusKidney and bone metabolism.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 15-3Breast cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
CYFRA 21-1Lung cancer marker.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).
PSAProstate cancer marker.
SCC antigenSquamous cell cancer marker (cervix, lung, head and neck).
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Syphilis serologySyphilis infection.
Urine & Stool
Stool occult blood (FIT)Colorectal cancer and polyps; the standard non-invasive colon screen.
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
10-year cardiovascular risk scoreA calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECGHeart rhythm and signs of prior heart damage.
Pulmonary
Lung function testAsthma, COPD and lung capacity.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.
Chest X-rayLung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Endoscopy
ColonoscopyColon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
Pap smearCervical cancer and precancer.
Eye
Color visionColor vision deficiency.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
Consultation
Physician physical examinationA doctor's hands-on examination and history taking.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Total bilirubin
Jaundice, liver and bile problems.
Total protein
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Calcium
Bone, parathyroid and kidney conditions.
Creatinine
Kidney function.
Electrolytes (Na, K, Cl)
Salt and fluid balance; kidney and hormone problems.
Phosphorus
Kidney and bone metabolism.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 15-3
Breast cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
CYFRA 21-1
Lung cancer marker.
EBV VCA-IgA
Nasopharyngeal cancer risk (common in Taiwan and southern China).
PSA
Prostate cancer marker.
SCC antigen
Squamous cell cancer marker (cervix, lung, head and neck).
Infection Serology
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Syphilis serology
Syphilis infection.
Urine & Stool
Stool occult blood (FIT)
Colorectal cancer and polyps; the standard non-invasive colon screen.
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
10-year cardiovascular risk score
A calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECG
Heart rhythm and signs of prior heart damage.
Pulmonary
Lung function test
Asthma, COPD and lung capacity.
X-ray
Abdominal X-ray (KUB)
Kidney stones and bowel abnormalities.
Chest X-ray
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Endoscopy
Colonoscopy
Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)
Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
Pap smear
Cervical cancer and precancer.
Eye
Color vision
Color vision deficiency.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
Consultation
Physician physical examination
A doctor's hands-on examination and history taking.
Also listed: Albumin/globulin ratio, Concentration, Fat mass, Gourmet wellness meal provided, H. pylori stool antigen test, Lean body mass, Low-residue meal replacement provided before exam, Mineral mass, Monocytes, etc., Muscle mass, Obstetrics and gynecology consultation, One-on-one physician report review, Palpation, etc., Red blood cell percentage, Urine sediment.

Before you book

SedationAvailable
Booking lead time14 days
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Chang Gung Memorial Hospital Taipei Health Examination Center
Taipei · Songshan

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

10 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Extra costs

  • The package price does not include the fee for removing a polyp if one is found during the endoscopy exam.

    Source ↗ · checked 2026-09-20

Booking and payment

  • Checkups are carried out Monday through Saturday.

    Source ↗ · checked 2026-09-20

Results

  • The checkup price does not include an imaging disc; burning one costs an additional fee.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$6,581–9,554 for a woman (52 of 55 tests) and US$6,169–9,042 for a man (49 of 52 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 0.8 mSv from the tests we could identify, a typical adult dose for these exams: roughly 4 months of natural background radiation (about 3 mSv a year, US average).

This package also lists 15 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Chest X-ray · about 0.1 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 24 of these tests
Hepatitis C antibody
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Blood pressure
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Breast ultrasound
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
CA 19-9
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Colonoscopy
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
10-year cardiovascular risk score
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Free T4
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hepatitis B surface antigen
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Height, weight and BMI
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
High-sensitivity CRP
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Intraocular pressure
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Pap smear
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
PSA
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Resting ECG
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Lung function test
Recommended against (grade D)The USPSTF recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults. (2022) · USPSTF ↗
Stool occult blood (FIT)
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT), to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Syphilis serology
Recommended (grade A/B)The USPSTF recommends screening for syphilis infection in nonpregnant persons who are at increased risk for infection. (2022) · USPSTF ↗
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Urinalysis
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Visual acuity
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 12 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Stool occult blood (FIT)

Guaiac-based kits usually ask you to avoid red meat, NSAIDs and more than 250mg of vitamin C for a few days beforehand; FIT kits usually need no diet change.

Mention when booking: Tell the center which kit you were given, and ask the prescribing doctor before stopping aspirin taken for the heart.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Lung function test

Usually asks for no smoking for 24 hours, no heavy meals for at least 2 hours, and no alcohol for at least 4 hours beforehand; wear loose clothing.

Mention when booking: Mention a recent heart attack, stroke or surgery, a chest infection, heart problems or uncontrolled blood pressure; ask whether to bring or hold your usual inhaler.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Colonoscopy

Usually needs a clear-liquid diet the day before and a split-dose bowel-cleansing prep taken the evening before and morning of the exam; drinking extra fluids helps avoid dehydration.

Mention when booking: Tell the center about heart, kidney or lung disease, blood thinners, diabetes medicine, aspirin, arthritis medicine or iron; ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, operating machinery or signing legal documents for the rest of the day; someone should take you home.

Gastroscopy (upper GI endoscopy)

Usually needs about 8 hours without food or drink, including water, beforehand.

Mention when booking: Tell the center about heart or lung disease, aspirin, blood thinners, arthritis medicine, insulin or iron, and ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, machinery or legal documents that day; get a ride home. Contact a doctor for fever, trouble swallowing, chest or belly pain, or black stools; bleeding can start days later.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Standard Painless GI Endoscopy Package
US$763
Book this checkup

If this isn't quite right

Same hospital, adds Echocardiogram
Standard Elite Package
Chang Gung Memorial Hospital Taipei Health Examination Center
US$794
Same focus, Hualien
Abundant Health Checkup
Mennonite Christian Hospital
US$779

Other packages at Chang Gung Memorial Hospital Taipei

PackageTestsPrice
Standard Elite Package75
US$794
NT$25,500
Women US$903
Standard Cardiovascular Package72
US$888
NT$28,500
Deluxe Painless GI Endoscopy Package79
US$966
NT$31,000
Women US$1,028
Deluxe Elite Package83
US$1,153
NT$37,000
Women US$1,246
Deluxe Cardiovascular Package74
US$1,713
NT$55,000
Men US$1,776
Deluxe Anti-Cancer Painless GI Endoscopy Package77
US$1,854
NT$59,500
Women US$1,947
Deluxe Glory Painless GI Endoscopy Package88
US$2,150
NT$69,000
Women US$2,181
VIP Whole-Body Imaging + Cardiopulmonary Package94
US$2,866
NT$92,000
Women US$2,897
VIP Whole-Body Imaging + Painless GI Endoscopy Package97
US$3,318
NT$106,500
Women US$3,364

All packages at Chang Gung Memorial Hospital Taipei Health Examination Center →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
MRI Scanning for Cerebrovascular Check-upShin Kong Wu Ho-Su Memorial Hospital Health Management Center27
US$841
NT$27,000
Gastrointestinal Health ProgramTaiwan Adventist Hospital Health Management Center45
US$679
NT$21,800
Cerebral Arteriosclerosis (Stroke) ProgramTaiwan Adventist Hospital Health Management Center37
US$592
NT$19,000
Cardiopulmonary Strengthening ProgramTaiwan Adventist Hospital Health Management Center41
US$561
NT$18,000
Painless Gastroscopy and Colonoscopy ExaminationTaiwan Adventist Hospital Health Management Center42
US$555
NT$17,800

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Stomach and colon · All checkups in Taipei · What a checkup costs in Taiwan